SUPN · Supernus Pharmaceuticals, Inc. · Investor Relations
$42.38
+0.20 (+0.47%)
At close · Oct 2
Return incl. dividend (before tax)
Market Cap
$2.48B
Shares
58.13M
Volume · Oct 2
739.81K
Avg daily vol (3M)
777.92K
Press releases and events scraped from the company’s investor relations website. Past events open our own call or event page when we host one; otherwise listings link to the original source.
Past events
| Date | Event | Type |
|---|---|---|
| 2026-08-03 | Q2 FY2026 Earnings conference call (announced in 8-K) | Earnings call |
| 2026-08-03 | Joint Supernus and Indivior Conference Call and Webcast | Conference |
| 2026-06-08 | Goldman Sachs 47th Annual Global Healthcare Conference | Conference |
| 2026-06-03 | 2026 Jefferies Global Healthcare Conference | Conference |
| 2026-05-12 | Bank of America 2026 Health Care Conference | Conference |
| 2026-05-05 | Supernus Pharmaceuticals 1Q 2026 Financial and Business Update Conference Call | Earnings call |
| 2026-03-11 | Barclays 28th Annual Global Healthcare Conference | Conference |
| 2026-03-10 | Jefferies Biotech on the Beach Summit | Event |
| 2026-03-02 | TD Cowen 46th Annual Health Care Conference | Conference |
| 2026-02-24 | Supernus Pharmaceuticals 4Q 2025 Financial and Business Update Conference Call | Earnings call |
Key facts
CIK
1356576
CUSIP
868459108
13F (30d)
10 filings
8 filers
Visit website
Investor relations